Banffshire and Buchan Coast MSP Stewart Stevenson said the investment will help meet needs in more remote locations.
It comes after the agreement with UK-based life sciences company LumiraDx to supply 300 rapid testing machines as well as a minimum of 500,000 tests.
The LumiraDx Platform instruments can be used anywhere making them ideal for local clinics or mobile units in Scotland’s rural communities.
Commenting, Stewart Stevenson MSP said:
“This announcement is superb news for communities across the north-east and the wider country.
“This is a great example of our pioneering life sciences sector in Scotland. I am pleased it will also help to support a quick turn around on testing, particularly in rural areas.”
“This is a great example of our pioneering life sciences sector in Scotland. I am pleased it will also help to support a quick turn around on testing, particularly in rural areas.”
The instruments connect to a cloud system, which means outbreaks of COVID-19 can be tracked quickly by health authorities playing a vital role in Scotland’s Test and Protect strategy.
The test was authorised for emergency use by the US Federal Drug Administration last week and is going through the final stages of validation for use in Scotland and Europe.